Dr. Ian Jones:

That is a matter we have really tuned into over the past 12 to 18 months. There is a real opportunity. We have not figured it out absolutely yet, but more returned emigrants are approaching us. It is more of a passive phenomenon right now. Emigrants return and then approach us saying they have certain skills and qualifications and they ask how they could enter pharma. That is the type of engagement. There are many more people who are still abroad who could benefit from these types of programmes.

The skills and experience emigrants generate abroad do not always match up with what exists in Ireland. Even with pharma, for example, there are more clinical trials, research and development and hardcore research abroad. Here there is less of that happening, but the returned emigrants would be brilliant at supporting roles more associated with formulation development and technical support. It is through generating an understanding of how that transfer could happen that we have helped people in the past. There are opportunities in that regard.